TY - JOUR
T1 - Cardiac magnetic resonance
T2 - Impact on diagnosis and management of patients with congenital cardiovascular disease
AU - Secchi, F.
AU - Di Leo, G.
AU - Papini, G. D E
AU - Nardella, V. G.
AU - Negura, D.
AU - Carminati, M.
AU - Sardanelli, F.
PY - 2011/8
Y1 - 2011/8
N2 - Aim: To estimate the clinical impact of cardiac magnetic resonance (CMR) in patients with congenital cardiovascular disease (CCD). Materials and methods: Since 2003, 1.5 T CMR was used at our university hospital to evaluate morphology, cardiac kinetics, aortic and pulmonary flow, and vascular anatomy in patients with CCD. The present study considered a consecutive series of these patients from 2003 to 2006. A paediatric cardiologist judged our reports as expected or unexpected and, secondarily, as not reliable (level 0), describing findings already known (level 1), not changing therapy/suggested lifestyle (level 2), changing therapy/suggested lifestyle (level 3) or changing diagnosis (level 4). Results: CMR reports were judged to be expected in 187/214 (87%) and unexpected in 27/214 (13%). Less than 2% of CMRs were judged as levels 0 or 1, 66% as level 2, and 5% as level 4. During 2005-2006 the clinical impact improved toward higher impact levels (p <0.001, chi-square test). Conclusions: In patients with CCD, more than one in 10 CMR reports were unexpected to cardiologists and over seven in 10 prompted a change of diagnosis or therapy.
AB - Aim: To estimate the clinical impact of cardiac magnetic resonance (CMR) in patients with congenital cardiovascular disease (CCD). Materials and methods: Since 2003, 1.5 T CMR was used at our university hospital to evaluate morphology, cardiac kinetics, aortic and pulmonary flow, and vascular anatomy in patients with CCD. The present study considered a consecutive series of these patients from 2003 to 2006. A paediatric cardiologist judged our reports as expected or unexpected and, secondarily, as not reliable (level 0), describing findings already known (level 1), not changing therapy/suggested lifestyle (level 2), changing therapy/suggested lifestyle (level 3) or changing diagnosis (level 4). Results: CMR reports were judged to be expected in 187/214 (87%) and unexpected in 27/214 (13%). Less than 2% of CMRs were judged as levels 0 or 1, 66% as level 2, and 5% as level 4. During 2005-2006 the clinical impact improved toward higher impact levels (p <0.001, chi-square test). Conclusions: In patients with CCD, more than one in 10 CMR reports were unexpected to cardiologists and over seven in 10 prompted a change of diagnosis or therapy.
UR - http://www.scopus.com/inward/record.url?scp=79959798837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959798837&partnerID=8YFLogxK
U2 - 10.1016/j.crad.2011.03.007
DO - 10.1016/j.crad.2011.03.007
M3 - Article
C2 - 21570066
AN - SCOPUS:79959798837
VL - 66
SP - 720
EP - 725
JO - Clinical Radiology
JF - Clinical Radiology
SN - 0009-9260
IS - 8
ER -